---
title: "Mereo BioPharma Group surges 8%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/303265156.md"
description: "Mereo BioPharma Group rose 8.18% to US$0.2975. Down 28.61% YTD."
datetime: "2026-10-27T16:40:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/303265156.md)
  - [en](https://longbridge.com/en/news/303265156.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/303265156.md)
generator: "portal-rs"
---

# Mereo BioPharma Group surges 8%

Mereo BioPharma Group (MREO.US) surged more than 8% during regular trading to $0.2975.

The stock is down 28.61% year to date and sits 48.75% above its 52-week low of US$0.2000.

The Nasdaq Composite is up 0.26% over the past five sessions and up 13.99% year to date.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [MREO.US](https://longbridge.com/en/quote/MREO.US.md)

## Related News & Research

- [Wall St Week Ahead-'Black Friday' brings consumer spending into focus for AI-rocked market](https://longbridge.com/en/news/306395310.md)
- [Profit Outlook Raised Could Change The Case For Zeta Global Stock](https://longbridge.com/en/news/306379536.md)
- [What Veeva Systems Stock AI Training Integration Means For Shareholders](https://longbridge.com/en/news/306379375.md)
- [Ross Gerber Tells Investors to 'Be Patient' on Anthropic Stock After Post-IPO Slide: ‘That Would Be a Gift’](https://longbridge.com/en/news/306388173.md)
- [Space Exploration Technologies (SPCX) Gets A New Hiring Twist As Musk Eyes Top AI Talent](https://longbridge.com/en/news/306383945.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**